Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yun Beom Sang"'
Autor:
Young Shin Song, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Ho Yeong Lim, Vincent E. Gaillard, Chan Kim, Hong Jae Chon
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Introduction: Atezolizumab and bevacizumab (Ate/Bev) combination has become the new first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). Although several studies reported thyroid dysfunction after treatment with immune checkpo
Externí odkaz:
https://doaj.org/article/e2d426249cb043a6bb5b0915904e89bc
Autor:
Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AXL, along with MER and TYRO3, is a receptor tyrosine kinase from the TAM family. Although AXL itself is not thought to be a potent oncogenic driver, overexpression of AXL is known to trigger tumor cell growth, survival, invasion, metastasis, angioge
Externí odkaz:
https://doaj.org/article/f5d17a5e34b34ab981c3f74270569ed3
Autor:
Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tract cancer (BTC) following treatment with nab-paclitaxel plus gemcitabine-cisplatin (Gem/Cis/nab-P). We aimed to evaluate the clinical outcomes of Gem
Externí odkaz:
https://doaj.org/article/145cac0366c7466f8d67f28f3b5655e5
Autor:
Youngun Kim, Hannah Yang, Won Suk Lee, Jaekyung Cheon, Yun Beom Sang, Beodeul Kang, Hong Jae Chon, Chan Kim
Publikováno v:
Journal of Cancer. 14:935-942
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::463d7e6cba02545c618a5e7963c9e62f
https://doi.org/10.7150/jca.81384
https://doi.org/10.7150/jca.81384
Autor:
Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim
Publikováno v:
Frontiers in oncology. 12
AXL, along with MER and TYRO3, is a receptor tyrosine kinase from the TAM family. Although AXL itself is not thought to be a potent oncogenic driver, overexpression of AXL is known to trigger tumor cell growth, survival, invasion, metastasis, angioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb14fce766fda03b95b0805fa28a0acc
https://pubmed.ncbi.nlm.nih.gov/35311091
https://pubmed.ncbi.nlm.nih.gov/35311091
Autor:
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Chan Kim
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5985
Renal cell carcinoma (RCC) is the most common type of kidney malignancy worldwide with Pembrolizumab and axitinib treatment (Pembro/Axi) amongst the most effective first-line immunotherapies for advanced RCC. However, it remains difficult to predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c9af58f5f1782c76be52a01e9be8d8
https://doi.org/10.3390/cancers14235985
https://doi.org/10.3390/cancers14235985
Autor:
Hong Jae Chon, Min Hwan Kim, Jaekyung Cheon, Chan Kim, Yun Beom Sang, Jun Ho Ji, Beodeul Kang, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Choong-kun Lee, Hye Jin Choi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tract cancer (BTC) following treatment with nab-paclitaxel plus gemcitabine-cisplatin (Gem/Cis/nab-P). We aimed to evaluate the clinical outcomes of Gem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41950f16699c85ae35c4d7e278d35a9
https://doaj.org/article/145cac0366c7466f8d67f28f3b5655e5
https://doaj.org/article/145cac0366c7466f8d67f28f3b5655e5
Publikováno v:
Journal of Clinical and Translational Hepatology. :000-000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67a37c704760d16cb476e9b206f2e40b
https://doi.org/10.14218/jcth.2022.00212
https://doi.org/10.14218/jcth.2022.00212
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 8035, p 8035 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 8035, p 8035 (2021)
Therapeutic cancer vaccines have become increasingly qualified for use in personalized cancer immunotherapy. A deeper understanding of tumor immunology and novel antigen delivery technologies has assisted in optimizing vaccine design. Therapeutic can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad865e0d76bfeec086a1137cf7f54f67
https://doi.org/10.3390/ijms22158035
https://doi.org/10.3390/ijms22158035